Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 10/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | CPT1A | P50416 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1025608 | 0.99 | ACKR3 (0.36) | ACKR3MAPK14KITCPT2CPT1A | |
| Hydrochloric Acid SCHEMBL1026430 | 0.92 | MAPK14 (0.33) | ACKR3MAPK14KIT | |
| SCHEMBL1029438 | 0.88 | ACKR3 (0.35) | ACKR3 | |
| Hydrochloric Acid SCHEMBL1024789 | 0.88 | ACKR3 (0.38) | ACKR3 | |
| Hydrochloric Acid SCHEMBL1026830 | 0.88 | ACKR3 (0.35) | ACKR3 | |
| SCHEMBL1024361 | 0.87 | MAPK14 (0.37) | ACKR3MAPK14KIT | |
| Hydrochloric Acid SCHEMBL1027402 | 0.86 | MAPK14 (0.36) | ACKR3MAPK14KIT | |
| Hydrochloric Acid SCHEMBL1025936 | 0.86 | ACKR3 (0.38) | ACKR3 | |
| SCHEMBL1025569 | 0.85 | ACKR3 (0.41) | ACKR3MAPK14KIT | |
| Hydrochloric Acid SCHEMBL1027455 | 0.85 | ACKR3 (0.37) | ACKR3CPT2CPT1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275404-A1 | HOMOCYSTEINE SYNTHASE INHIBITOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |